Fortis Biosciences is a biotechnology startup, established in 2013 and headquartered in the United States. The company focuses on integrating translational microbiome research with human metabolomics to introduce modern biotherapeutic approaches globally. Fortis is committed to leveraging cutting-edge technology and approaches to research endogenous microbiota-mediated mechanisms that influence human health. Their ultimate goal is to translate these discoveries to create the next generation of biologic therapeutics.
Fortis Biosciences received a $5.00K grant investment on 16 May 2017 from Texas A&M Innovation.
This investment is indicative of the confidence that Texas A&M Innovation has in Fortis Biosciences' innovative approach to biotechnology and healthcare. It also reflects the potential that Fortis Biosciences holds in revolutionizing biotherapeutics through its unique integration of microbiome research and human metabolomics. As the company continues its research and development efforts, it is poised to make significant contributions to the advancement of biologic therapeutics.| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $5.00K | 1 |
|
16 May 2017 |
No recent news or press coverage available for Fortis Biosciences.
We care about your data, and we'd love to use cookies make your experience better.